medigraphic.com
SPANISH

Gaceta Médica de México

ISSN 0016-3813 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2002, Number 5

<< Back Next >>

Gac Med Mex 2002; 138 (5)

Carcinoma renal de células cromófobas. Un estudio clínico patológico de 36 casos.

Alvarado-Cabrero I, Atencio-Chan A, Rodríguez C, Sosa-Romero A
Full text How to cite this article

Language: Spanish
References: 15
Page: 421-426
PDF size: 372.40 Kb.


Key words:

Carcinoma, kidney, chromophobe.

ABSTRACT

Introduction: Chromophobe renal cell carcinoma (CCRC) comprises 5% of neoplasms of renal tubular epithelium. CCRC may have a slightly better prognosis than clear cell carcinoma, but outcome data are limited. Objective: In this study. we analyzed 250 renal cell carcinomas to a) determine frequency of CCRC at our Hospital and b) analyze clinical and pathologic features of CCRCs. Methods: A total of 250 renal carcinomas were analyzed between March 1990 and March 1999. Tumors were classified according to well-established histologic criteria to determine stage of disease; the system proposed by Robson was used Results: Of 250 renal cell carcinomas analyzed, 36 were classified as chromophobe renal cell carcinoma, representing 14% of the group studied. The tumors had an average diameter of 14 cm. Robson staging was possible in all cases, and 10 patients were stage 1) 11 stage II; 10 stage III, and five stage IV. The average follow-up period was 4 years and 18 (53%) patients were alive without disease. Conclusion: The highly favorable pathologic stage (RI-RII, 58%) and the fact that the majority of patients were alive and disease-free suggested a more favorable prognosis for this type of renal cell carcinoma.


REFERENCES

  1. Epidemiología. En: Registro Histopatológico de Neoplasias en México. Secretaría de Salud, México. 1999-2000.

  2. Bannash P, Schacht U, Storch E. Morphogenese und mikromorphologie epitheliarler. Induktion und Histologie der Tumoren 1974;81:311-331.

  3. Thoenes W, Storkel S, Rumpelt HJ. Human chromophobe renal cell carcinoma. Virchows Arch 1985;48:207-217.

  4. Kovacks A, Kovacks G. Low chromosome number in chromophobe renal cell carcinomas. Genes Chromosomes Cancer 1992;4:267-268.

  5. Presti JC Jr, Rao PH, Chen Q, et al. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. Cancer Res 1991;51;1544-1552.

  6. Fuhrman S, Lasky J, Limas C. Prognostic’s significance of morphologic renal parameters in cell carcinoma. Am J Surg Pathol 1982;6:655-663.

  7. Robson CJ. Radical nephrectomy for renal cell carcinoma. J Urol 1963;89:3742.

  8. Medeiros LJ, Weiss LM. Renal adenocarcinoma. In: Eble JN, Ed. Tumors and tumor-like conditions of the kidneys and ureters. Churchill Livingstone. New York, 1990.

  9. Alvarado-Cabrero I, Atencio A, Rodriguez C. Carcinoma de células cromófobas. Un estudio clínico-patológico de 34 casos. Patología 2001;39:53.

  10. Crotty TB, Farrow GM, Lieber MM. Chromophobe renal cell carcinoma: Clinicopathological features of 50 cases. J Urol 1995;154:964-967.

  11. Akhtar M, Tulbah A, Kardar A, et al. Sarcomatoid renal ceIl carcinoma: The chromophobe connection. Am J Surg Pathol 1997;21:1188-1195.

  12. Thoene W, Storkel S, Rumpelt HJ, et al. Chromophobe cell renal carcinoma and its variants. A report on 32 cases. J Pathol 1988;155:277-287.

  13. Bonsib SM. Renal chromophobe cell carcinoma: The relationship between cytoplasmic vesicles and colloidal iron stain. J Urol Pathol 2000;18:560-564.

  14. Amin MB, Moch U, Alvarado-Cabrero I, Jimenez RE, et al. Chromophobe renal cell carcinoma: Histopathologic and prognostic features in 116 cases. Mod Pathol 2001;14:S578.

  15. Alvarado-Cabrero I, Atencio-Chan A, Gayborg J, Rodriguez C. Factores pronósticos asociados a la sobrevida de pacientes con carcinoma de células renales. En preparación para publicación.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Gac Med Mex. 2002;138